Erythromycin pediatric dose calculator
Use this Erythromycin pediatric dose calculator to match the prescribed child dose to the exact liquid, tablet, or capsule strength before you give it.
dose calculator basics
Erythromycin (EES) pediatric dose calculator details
Use this Erythromycin (EES) calculator as the fast parent page for weight-based dose checks, mL conversion, common strengths, and the practical safety steps that generic calculator sites often skip.
Formula
mL per dose = (child weight in kg x prescribed mg/kg/day / doses per day) / medication concentration in mg per mL.
Worked example
For a 20 kg child using 40 mg/kg/day divided 4 times daily with 200 mg/5 mL, calculate the daily mg target, divide by the schedule, then convert that mg amount into mL for the selected product.
Safety checks before using the result
- Use the exact product strength in hand before measuring the dose.
- Confirm maximum dose, age limits, and indication-specific cautions when they apply.
- Escalate urgent symptoms or medication reactions instead of repeating doses from calculator output alone.
Practical dosing guide
Before you measure the dose
Use this page to match the prescribed Erythromycin plan to the exact product strength and schedule before the first dose.
- Common outpatient uses
- Macrolide antibiotic used for pertussis, neonatal chlamydial infections, and atypical pneumonias when newer agents are not suitable.
- Common forms
- Common forms include 200 mg/5 mL oral liquid, 400 mg/5 mL oral liquid, and 400 mg tablet.
- How the schedule is usually written
- Many outpatient plans are given 4 times per day for 5 to 14 days.
Erythromycin (EES) pediatric medication summary
Macrolide antibiotic used for pertussis, neonatal chlamydial infections, and atypical pneumonias when newer agents are not suitable.
Weight-based dosing (40 to 50 mg/kg/day divided every 6 hours for many infections) requires caregiver adherence to multiple daily doses.
Classic uses include treatment and post-exposure prophylaxis for pertussis, chlamydial conjunctivitis in neonates, and atypical pneumonias caused by Mycoplasma pneumoniae or Chlamydia pneumoniae.
Erythromycin (EES) indications and common pediatric uses
Erythromycin is a pediatric macrolide option for selected infections and limited specialist-directed off-label use when benefit outweighs its interaction and tolerability burden.
Pertussis (Bordetella pertussis) treatment and post-exposure prophylaxis
Pertussis (Bordetella pertussis) treatment and post-exposure prophylaxis: Reasonable option when preferred macrolides are not suitable or available.
Neonatal Chlamydia trachomatis conjunctivitis or pneumonia
Neonatal Chlamydia trachomatis conjunctivitis or pneumonia: Use close follow-up to watch for HPS symptoms and treatment response.
Atypical community-acquired pneumonia (Mycoplasma, Chlamydophila)
Atypical community-acquired pneumonia (Mycoplasma, Chlamydophila): If local resistance is high or response is poor, reassess quickly and switch therapy as indicated.
Group A streptococcal pharyngitis with severe beta-lactam allergy
Group A streptococcal pharyngitis with severe beta-lactam allergy: Culture/susceptibility review is useful where macrolide resistance is common.
Ophthalmia neonatorum prophylaxis (topical)
Ophthalmia neonatorum prophylaxis (topical): Use as routine newborn prophylaxis per public health guidance.
Gastroparesis or delayed gastric emptying (motilin agonist)
Gastroparesis or delayed gastric emptying (motilin agonist): Reserve for specialist-directed short courses with explicit stop/reassess criteria.
How to give Erythromycin (EES)
- Practical pediatric administration guidance for erythromycin ethylsuccinate (EES).
- Use the indication-specific dose from the prescribing clinician, typically divided through the day. Shake well, measure with a metric oral syringe, and record each dose to prevent missed or duplicate administrations.
- Build dosing into predictable anchors (morning, midday, evening, bedtime), pre-brief school caregivers, and document the formulation strength in all handoffs.
Erythromycin (EES) side effects, contraindications, and interactions
Erythromycin side effects are often gastrointestinal and can disrupt adherence if families are not coached early. High-risk events are less common but need explicit red-flag instructions before treatment starts.
Common side effects
- Use a small snack when needed to improve tolerance and preserve schedule adherence.
- Report vomiting, jaundice, dark urine, or pale stools promptly because these may signal hepatic injury.
- Reconcile all medicines and supplements for QT/CYP interaction risk before and during therapy.
Safety checks
- Severe hypersensitivity reaction to erythromycin or other macrolides
- Co-administration with cisapride, pimozide, ergotamine/ergot derivatives, or astemizole/terfenadine
- Known congenital long QT syndrome or prior macrolide-associated torsades de pointes
- Moderate to severe hepatic dysfunction (cholestatic hepatitis risk)
- Electrolyte abnormalities (hypokalemia, hypomagnesemia)
- Concurrent QT-prolonging agents (ondansetron, fluoroquinolones, tricyclic antidepressants, antipsychotics)
Drug interactions
- Review the full medication list with a clinician or pharmacist before combining therapies.
Erythromycin (EES) mechanism and clinical pearls
Erythromycin acts primarily by binding the bacterial 50S ribosomal subunit (23S rRNA) and blocking peptide-chain translocation, which suppresses protein synthesis in susceptible organisms. In pediatrics this supports use in selected macrolide-sensitive infections such as pertussis and atypical respiratory pathogens. The same molecule also stimulates motilin receptors, which explains both its occasional prokinetic use and frequent GI intolerance. Because erythromycin inhibits CYP3A pathways and can increase QT risk in susceptible patients, mechanism knowledge should always be paired with interaction screening and symptom monitoring.
Set up a written schedule with backup caregiver coverage before first dose; frequent dosing fails most often from handoff gaps.
Review every prescription, OTC, and herbal agent; cisapride, pimozide, ergot derivatives, and many psych meds are off-limits.
For neonatal treatment, plan early follow-up and clearly teach warning signs such as projectile vomiting, poor intake, and reduced wet diapers.
Separate antacids and calcium-heavy products from doses when possible to reduce avoidable exposure loss.
Frequently asked questions about Erythromycin (EES)
Children often feel better within a few days of treatment as coughing paroxysms lessen and fevers improve, but the full course (typically 14 days for pertussis) must be completed to eradicate the bacteria and limit transmission.
Yes. Giving doses with a small meal or snack can reduce stomach upset and does not significantly affect absorption of the ethylsuccinate suspension. Avoid large amounts of grapefruit juice, which can increase medicine levels.
In infants younger than 2 weeks, monitor for vomiting, feeding intolerance, or projectile emesis and call your clinician if these occur; very rarely erythromycin has been linked to hypertrophic pyloric stenosis.
If vomiting occurs within 15 minutes and the medicine is visible, repeat the dose once. If vomiting persists or the child cannot keep fluids down, call your clinician—an IV formulation or different antibiotic may be needed.
Erythromycin can raise levels of certain medicines (theophylline, carbamazepine, warfarin, statins) and may prolong the QT interval when combined with other arrhythmia-risk drugs. Always share a full medication list so your clinician can adjust or monitor therapy.
Go to the ED for trouble breathing, swelling of the face or throat, severe rash with blisters, jaundice, or signs of arrhythmia such as fainting or palpitations. Bring the medication bottle so clinicians know the formulation and strength.
Sources reviewed for Erythromycin (EES)
cdc-pertussis-2024
cdc-chlamydia-2024
idsa-cap-2011
idsa-gas-2012
cdc-ophthalmia-2021
gastrojournal-gastroparesis-2020